جستجوی استاد راهنمای دانشگاهی

Soh Youn Suhمشاهده پروفایل

استادیار

• Pediatric Ophthalmology
• Strabismus
• Neuro-Ophthalmology
• +۳ مورد دیگر

Dr. Soh Youn Suh serves as an Assistant Professor of Ophthalmology at UCLA's Stein Eye Institute within the David Geffen School of Medicine, specializing in pediatric ophthalmology and adult strabismus care at the Los Angeles clinical site. Her clinical expertise addresses complex eye alignment disorders and childhood vision conditions. Education: MD, Ewha Womans University School of Medicine, 2006 MS, Ewha Woman's University, 2010 Ophthalmology Residency, Ewha Womans University Medical Center, 2011 Pediatric Ophthalmology & Neuro-Ophthalmology Fellowship, Seoul National University Hospital, 2013 Pediatric Ophthalmology & Adult Strabismus Fellowship, Stein Eye Institute, UCLA, 2014 Research Fellowship, Ocular Motility Laboratory, Stein Eye Institute, UCLA, 2018 Her research program investigates biomechanical interactions between extraocular muscles, optic nerves, and orbital structures using advanced MRI and OCT imaging. Key discoveries include documenting abnormal optic nerve traction during eye movements in glaucoma patients with normal intraocular pressure and characterizing muscle pulley displacements in strabismus conditions. This work bridges neuro-ophthalmology and surgical planning through quantitative orbital analysis. Analysis of her 15 most recent publications (2020-2025) reveals three dominant research trajectories: (1) AI-driven segmentation of orbital structures using deep learning, (2) cerebrospinal fluid dynamics in optic neuropathies, and (3) biomechanical modeling of optic nerve strain during horizontal eye movements. These studies increasingly integrate computational methods with high-resolution imaging to decode pathophysiological mechanisms in strabismus and glaucoma. Scientific Recognition: Excellence in Research Award, Stein Eye Institute (2015) Excellence in Research Award, Stein Eye Institute (2016) Excellence in Research Award, Stein Eye Institute (2018) Dr. Suh has developed collaborative research partnerships through UCLA's institutional resources, particularly within Dr. Joseph L. Demer's ocular motility laboratory where she conducted postdoctoral research. Her work receives consistent institutional support through Stein Eye Institute infrastructure, though specific external grant funding isn't documented in source materials. She actively contributes to training through co-authorship with junior researchers on technical imaging studies. Her current research team at the Stein Eye Institute operates an orbital biomechanics laboratory focused on translating MRI/OCT findings into clinical applications. The group specializes in computational modeling of eye movement dynamics and developing AI tools for surgical planning in complex strabismus cases, with ongoing projects examining cerebrospinal fluid interactions in optic nerve disorders.

• Pediatric Endocrinology
• Congenital Hypothyroidism
• Molecular Pathophysiology
• +۵ مورد دیگر

Prof. Guy Van Vliet is a Full Professor in the Department of Pediatrics at the University of Montreal and Chief of the Endocrinology Service at CHU Sainte-Justine. He completed medical school at the Free University of Brussels (1976), followed by pediatric residency and a fellowship at UCSF (1980-1983). His research focuses on molecular mechanisms of congenital hypothyroidism, neonatal screening, and pediatric endocrine disorders, with over 220 publications. He has pioneered studies on thyroid disorders in children and contributed to international guidelines for congenital hypothyroidism management. Education: Medical Doctorate (Free University of Brussels, 1976), Pediatric Endocrinology Fellowship (UCSF, 1980-1983). Research Interests: Molecular pathophysiology of congenital hypothyroidism, genetic basis of endocrine disorders in children, neonatal screening efficacy, and long-term outcomes of thyroid hormone replacement. He emphasizes translational research connecting molecular findings to clinical care, particularly in pediatric endocrinology. Key Articles: Focus on improving screening protocols, understanding genetic mechanisms in thyroid disorders, and optimizing treatment strategies for congenital hypothyroidism. Recent work critiques overdiagnosis risks in premature infants and explores redefining diagnostic criteria based on molecular insights. Awards: Not explicitly listed in provided texts. Advising/Grants: Advised numerous students and led collaborative projects on endocrine disorders. Active in clinical trials and guideline development for congenital hypothyroidism. Labs/Teams: Affiliated with the Azrieli Research Center at CHU Sainte-Justine, focusing on pediatric endocrine research and translational medicine.

• Clinical Trials
• Medical Statistics
• Risk-Benefit Decision Making
• +۳ مورد دیگر

Professor Deborah Ashby serves as Dean of the Faculty of Medicine at Imperial College London and holds the Chair in Medical Statistics and Clinical Trials. She previously directed the School of Public Health and co-founded the Imperial Clinical Trials Unit. Her research focuses on clinical trials methodology, risk-benefit analysis for medications, and Bayesian statistical approaches. She has held prestigious roles including Royal Statistical Society President (2019-2020) and was elected to the Royal Society in 2025. Notable accolades include an OBE (2009), NIHR Senior Investigator designation (2010), and Academy of Medical Sciences membership (2012). Her work has significantly impacted national pandemic response through the REACT studies, analyzing SARS-CoV-2 prevalence and antibody dynamics across millions of participants. Key contributions: Development of SPIRIT-DEFINE and CONSORT-DEFINE guidelines for dose-finding trials Leadership roles: Academic governance, cross-disciplinary collaboration in public health Current initiatives: Advancing medical statistics education and translational research Her research portfolio includes over 200 peer-reviewed articles addressing pandemic dynamics, clinical trial design, and healthcare evaluation. Ongoing work focuses on optimizing diagnostic testing strategies and improving benefit-risk frameworks in therapeutic development.

Haiyan Zhengمشاهده پروفایل

دانشیار

• Clinical Trials
• Precision Medicine
• Bayesian Statistics
• +۳ مورد دیگر

Haiyan Zheng is a Reader in the Department of Mathematical Sciences at the University of Bath, affiliated with the EPSRC Centre for Doctoral Training in Statistical Applied Mathematics (SAMBa) and the Institute for Mathematical Innovation (IMI). She holds visiting roles at the MRC Biostatistics Unit and the Institute of Cancer Research. Her research focuses on advancing clinical trial methodologies, particularly in precision medicine, with an emphasis on Bayesian approaches, adaptive designs, and multi-agent trial optimizations. Key areas include improving trial efficiency through data borrowing, mid-trial adaptations, and simultaneous treatment/subgroup evaluations. Her work bridges statistical innovation with practical clinical applications, addressing challenges in oncology trials, biomarker utilization, and rare disease research. She leads projects funded by Cancer Research UK and the National Institute for Health Research, focusing on statistically efficient trial designs and seamless protocol implementations. Haiyan is actively involved in training doctoral students through SAMBa, requiring a strong quantitative background. Recent research trends include developing Bayesian hierarchical models for basket trials, integrating preclinical data into early-phase oncology studies, and optimizing sample size determination through robust priors. Her contributions emphasize reproducibility, safety monitoring, and cross-subgroup analysis in adaptive trial frameworks. Notable grants include the £5M STEEP project (2024–2030) for precision medicine trials and the IDEAS initiative (2023–2024) enhancing oncology trial design. She collaborates internationally to advance methodologies for late-onset toxicity handling and biomarker-guided trial interpretation.

TAN Say Bengمشاهده پروفایل

دانشیار

• Clinical Trials
• Biostatistics

TAN Say Beng is an Associate Professor jointly appointed at the National University of Singapore's Saw Swee Hock School of Public Health, while holding primary roles as Group Director of Research at SingHealth and Senior Associate Dean in Duke-NUS Medical School's Office of Clinical Sciences. His extensive leadership includes directing national research initiatives and biostatistics units across Singapore's healthcare ecosystem. Education: He holds a PhD, MSc, and MA, though specific disciplines and awarding institutions are not detailed in the source material. Research Focus: His expertise centers on two interconnected domains: Clinical Trials : Specializing in methodological innovations for trial design (including Bayesian approaches and adaptive designs), strategies for rare disease studies, and efficiency optimization in randomized controlled trials. Biostatistics : Developing quantitative frameworks for oncology outcomes, survival analysis, and epidemiological modeling, with applications in liver cancer and surgical prognostics. Publication Themes: His scholarly work (2002-2014) demonstrates progression from foundational statistical methodologies to applied clinical research. Early publications established Bayesian frameworks for Phase II trials and rare cancer strategies, while later works translated these methods into oncology practice—particularly in hepatocellular carcinoma therapy optimization and surgical outcome prediction.

Matthew J. Smithمشاهده پروفایل

استاد

• Autism
• Schizophrenia
• Technology-based Interventions
• +۴ مورد دیگر

Matthew J. Smith, PhD, MSW, MPE, LCSW is a faculty member at the University of Michigan School of Social Work where he serves as director of the NIH-Funded Level Up: Employment Skills Simulation Lab and Associate Dean for Research. His research focuses on developing and evaluating technology-based interventions to help marginalized and underserved communities obtain and sustain employment. Dr. Smith received his PhD in Social Welfare from the University of Wisconsin-Madison in 2006, completed post-doctoral fellowships in psychiatric epidemiology at Washington University and translational neuroscience at Northwestern University, and holds degrees in Psychiatric Epidemiology, Social Work, and Psychology. His educational background reflects his interdisciplinary approach to mental health and employment research. His primary research interests include Autism , Schizophrenia , Technology-based Interventions , and Social Neuroscience . Dr. Smith partners directly with members of autism, mental health, and system-impacted communities to develop employment-focused tools that are evaluated in real-world settings including high schools, community mental health agencies, and re-entry programs. Dr. Smith's recent publications demonstrate a concentrated focus on virtual reality job interview training for transition-age youth with disabilities, particularly those on the autism spectrum. His work examines dose-response relationships, implementation strategies across diverse settings, and adaptations for specific populations including BIPOC communities and individuals with visual impairments, reflecting his commitment to equitable access to employment opportunities. 2025 DSO Faculty Award MICHR 2024 Distinguished Clinical and Translational Research Mentor Award Dr. Smith has secured substantial grant funding from numerous sources including multiple awards from the National Institute of Mental Health (R01 MH110524, R34 MH111531, R44 MH123359, R01 MH112625, R01 MH132656), National Institute of Justice (2019-MU-MU-0004), National Institute on Disability, Independent Living, and Rehabilitation Research (90IFRE0031, 90IFDV0032), Kessler Foundation (1003-1958-SEG-FY2016), Michigan Institute for Clinical and Health Research, and U-M's Poverty Solutions. As director of the Level Up Lab, Dr. Smith leads a multidisciplinary team developing and evaluating technology-based employment interventions. His lab's mission centers on creating tools that address real-world employment challenges faced by marginalized populations, with a strong emphasis on community partnership to ensure cultural relevance and practical utility of their interventions.

• Infectious Diseases
• Tuberculosis Epidemiology
• Vaccinology
• +۷ مورد دیگر

Dr. Julio Croda is an accomplished physician-scientist serving as Associate Professor Adjunct of Epidemiology in the Department of Epidemiology of Microbial Diseases at Yale School of Public Health. He also holds positions as Associate Professor at the Federal University of Mato Grosso do Sul and as a Researcher at the Oswaldo Cruz Foundation in Mato Grosso do Sul. His extensive academic background includes an MD from the Federal University of Bahia (2003), Residency at São Paulo University (2007), and a PhD from São Paulo University (2008). MD, Federal University of Bahia, Medicine (2003) Residency, São Paulo University (2007) PhD, São Paulo University (2008) Dr. Croda's research spans multiple critical areas of global health with a particular focus on infectious diseases. His work demonstrates expertise in tuberculosis epidemiology, vaccinology, arboviruses, and emerging infectious diseases including COVID-19. He has made significant contributions to understanding disease transmission dynamics, particularly in vulnerable populations such as indigenous communities and prison settings. His approach uniquely combines clinical trials, communicable disease surveillance, and programmatic data analysis to develop evidence-based public health strategies. Dr. Croda's work is characterized by its strong emphasis on health equity, addressing disparities in disease burden and healthcare access across different populations. Analysis of Dr. Croda's recent publications reveals a strong focus on tuberculosis and emerging infectious diseases, with particular attention to vaccine development and evaluation. His work spans multiple continents but maintains a strong focus on South American epidemiology, especially in Brazil. The research demonstrates methodological diversity, incorporating clinical trials, genomic epidemiology, mathematical modeling, and population-based studies. A notable theme across his publications is the examination of health disparities, particularly among indigenous populations and incarcerated individuals. His work on fractional dosing of vaccines represents innovative approaches to resource-limited settings, while his research on Oropouche virus documents the emergence and spread of previously obscure pathogens. July 2nd Commendation from Legislative Assembly of Bahia, Brazil (2023) Researcher Award Sul-Mato-Grossense, First Place in Outstanding Researcher Category, Life Sciences Subcategory (2021) Sergio Arouca Health and Citizenship Award – Oswaldo Cruz Foundation (2021) Dr. Croda has secured substantial research funding from prestigious sources including the National Institutes of Health (NIH) and Brazilian funding agencies such as CNPq and CAPES. His leadership extends beyond research to significant advisory roles, including membership on multiple Technical Advisory Chambers at the Ministry of Health of Brazil for Public Health Emergencies, Surveillance of Respiratory Viruses, and Immunizations. He has held prominent leadership positions including President of Rede-TB and President of the Brazilian Society of Tropical Medicine. His work bridges academic research and public health practice, with a demonstrated commitment to translating scientific findings into actionable public health interventions that address health disparities and promote health equity.

• Neurorehabilitation
• Stroke Recovery and Rehabilitation
• Personalized Medicine in Rehabilitation
• +۷ مورد دیگر

Professor Valerie Pomeroy is a leading academic in neurorehabilitation at the University of East Anglia (UEA), where she holds the Chair in Neurorehabilitation within the School of Health Sciences. She is a member of the Norwich Institute for Healthy Aging, Lifespan Health, and leads research in acquired brain injury rehabilitation. Her work is supported by major funding bodies including the National Institute for Health and Care Research (NIHR) and NHS boards. PhD, University of Southampton, School of Medicine BA, GradDipPhys, Cambridge School of Physiotherapy Professional Qualifications: FCSP, Member of Association of Chartered Physiotherapists in Neurology, Society for Research in Rehabilitation, Stroke Society of Australasia Her research focuses on personalized neurorehabilitation , particularly in stroke recovery and rehabilitation . She investigates movement control , neural correlates of therapy response , and the mechanisms underlying impairment and recovery. Her program emphasizes Phase I and II clinical trials to inform larger efficacy studies, integrating biomechanical and neurophysiological methods. She actively explores functional strength training, telerehabilitation, and novel neuromodulation techniques. Recent publications highlight her work in telerehabilitation , mirror movement therapy , kinematic assessment of movement , and neurophysiological monitoring post-stroke. Her studies span dose-finding trials, reliability assessments, and protocol development for large-scale interventions. The overarching trend is toward precision rehabilitation—understanding which therapies work, for whom, and under what conditions. Scientific contributions include editorial leadership and national policy input: Associate Editor, Physiotherapy (since 1998) Contributor to national and international reports/position papers (since 2007) Professor Pomeroy leads or collaborates on multiple active research projects, including NIHR-funded trials on spatial neglect (SIGHT), brain injury rehabilitation, and the neural mechanisms of mirror therapy. She supervises and collaborates with a broad team of researchers, though specific students are not listed. Her work is conducted through the Acquired Brain Injury Rehabilitation Alliance at UEA, where she integrates clinical innovation with scientific rigor.

Jing Sunمشاهده پروفایل

دانشگاهی

• Epidemiology
• HIV/AIDS
• Biomarkers
• +۶ مورد دیگر

Jing Sun, MD, PhD, MPH is an Associate Research Professor in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. Her primary departmental affiliation is with the Infectious Disease Epidemiology division, and she holds significant center affiliations including the Johns Hopkins Center for AIDS Research (CFAR) and the AIDS Linked To the Intravenous Experience (ALIVE) cohort study. She is also involved with the MACS/WIHS Combined Cohort Study and contributes to the National COVID Cohort Collaborative (N3C). Dr. Sun earned her MD from Guangdong Medical University (2008), MPH from the University of Wisconsin (2011), and PhD from Drexel University (2015). Her educational background spans clinical medicine, public health, and epidemiological research methods. As a molecular epidemiologist specializing in HIV and aging, Dr. Sun's research focuses on molecular factors impacting long-term health outcomes of people living with chronic infections, particularly HIV and viral hepatitis. Her work centers on investigating age-related biomarkers, especially mitochondrial function, on multi-organ aging among people living with HIV. She also examines the impact of viral hepatitis and HIV coinfections on liver disease progression. During the COVID-19 pandemic, her research with the N3C addressed risk of severe outcomes and vaccine effectiveness among immunocompromised populations, with findings cited by the CDC in vaccine prioritization decisions. Her extensive publication record (55+ publications) demonstrates consistent research productivity, with recent work spanning HIV and aging, injection drug use epidemiology, social determinants of health, and the intersection of HIV with emerging infectious diseases like COVID-19. Her research employs diverse methodologies including molecular epidemiology, cohort studies, computational phenotyping, and machine learning approaches to identify risk factors and health disparities. Dr. Sun has received numerous prestigious awards including the CFAR Scholar Faculty Development Award (2019), Cooper Scholar designation (2018), New Investigator Scholarship at CROI (2018), and multiple travel and mentoring awards supporting her work in HIV and aging research. Her collaborative research involves significant work with the ALIVE cohort (a longitudinal study of people who inject drugs in Baltimore), the MACS/WIHS Combined Cohort Study, and the National COVID Cohort Collaborative. She frequently collaborates with interdisciplinary teams spanning epidemiology, infectious diseases, biostatistics, and computational sciences to address complex questions in HIV epidemiology and aging.

Yotam Shem-Tovمشاهده پروفایل

استادیار

• labor economics
• criminal justice
• crime
• +۱ مورد دیگر

Yotam Shem-Tov serves as an Assistant Professor of Economics at the University of California, Los Angeles (UCLA), with affiliations at the National Bureau of Economic Research (NBER) and the Institute of Labor Economics (IZA). Recognized with the prestigious Sloan Research Fellowship, his work bridges economic theory and real-world policy analysis. His research spans labor economics, criminal justice systems, crime dynamics, and advanced econometric methodologies. Key investigations examine incarceration's economic impacts, restorative justice efficacy, teacher quality effects on criminal trajectories, and combat deployment consequences for veterans. His methodological contributions include innovative causal inference techniques for ordered treatments and multivariate distribution testing. Analysis of his 15 most recent publications reveals a dominant focus on criminal justice reform through economic lenses, featuring quasi-experimental designs and policy-relevant findings. Over 60% of his work since 2019 addresses policing, incarceration, or judicial interventions, demonstrating sustained commitment to evidence-based criminal justice solutions. Scientific recognition includes: Sloan Research Fellowship His collaborative research network involves scholars from NBER, IZA, and institutions like UC Berkeley, with frequent co-authorship with Evan K. Rose. While student advising details are unavailable, his publications acknowledge contributions from research teams across multiple universities and policy labs.

Marie Davidianمشاهده پروفایل

استاد

• Biostatistics
• Longitudinal Analysis
• Clinical Trials
• +۴ مورد دیگر

Marie Davidian is the J. Stuart Hunter Distinguished Professor of Statistics at North Carolina State University (NC State) and Director of Faculty Grants. She holds an adjunct position at Duke University's Department of Biostatistics and Bioinformatics. Her primary research focuses on statistical methods for dynamic treatment regimes, clinical trial design, longitudinal data analysis, and handling missing/mismeasured data. Davidian earned her Ph.D. in Statistics from the University of North Carolina at Chapel Hill in 1987 under Raymond J. Carroll. She has led significant training initiatives, including co-directing the Integrated Biostatistical Training Program for CVD Research (2006–2021) and the Summer Institute in Biostatistics (SIBS, 2004–2019). These programs emphasized cardiovascular disease research collaboration and biostatistical methodology. Her educational contributions include courses on longitudinal data analysis, missing data methods, and precision medicine. Her research interests span statistical methodologies for personalized medicine, causal inference, and pharmacokinetic modeling. She has been recognized with the Dr. D. D. Mason Award (2011–2012) and contributed to high-impact studies in oncology, HIV treatment, and chronic disease management. Davidian’s work bridges methodological innovation with practical applications in healthcare, emphasizing translational research and interdisciplinary collaboration.

Keying Yeمشاهده پروفایل

استاد

• Bayesian inference
• Objective Bayesian analysis
• Normalized power Bayesian analysis
• +۷ مورد دیگر

Keying Ye is a Professor of Statistics in the Department of Management Science and Statistics at The University of Texas at San Antonio (UTSA), part of the Alvarez College of Business. Previously, he held positions at Virginia Tech (1990–2005) and Shanghai Jiaotong University (1985). He earned his Ph.D. in Statistics from Purdue University, an M.S. in Mathematics from the Institute of Applied Mathematics at Academia Sinica (China), and a B.S. in Mathematics from Fudan University (China). Research Interests : Bayesian inference and methods, objective Bayesian analysis, normalized power Bayesian analysis, clinical trial design (e.g., Continual Reassessment Method), variable selection, Bayesian model averaging, and applications in biostatistics, cyber security, environmental science, and experimental design. He currently serves as an Associate Editor for Bayesian Analysis . His teaching spans courses such as Bayesian statistics, regression analysis, statistical learning, and advanced inference methods. His publications focus on methodological advancements and applied statistical solutions in diverse fields.

Tormod Skogstad Nilsenمشاهده پروفایل

دانشیار

• Exercise Oncology
• Strength Training
• Muscle Physiology
• +۲ مورد دیگر

Tormod Skogstad Nilsen serves as an Associate Professor at the Institute of Physical Performance at the Norwegian School of Sport Sciences. He holds both a master's degree and PhD from the same institution and is actively engaged in research on exercise interventions for cancer patients and survivors. His work bridges sports science and oncology, with a particular focus on understanding how physical activity can mitigate treatment side effects and improve quality of life. Dr. Nilsen's research interests center on exercise oncology, with special emphasis on strength training adaptations and muscle physiology in cancer contexts. His work spans multiple cancer types including prostate cancer (particularly examining effects of androgen deprivation therapy), breast cancer survivors, and patients undergoing various cancer treatments. He investigates how exercise impacts cardiovascular health, muscle function, and overall quality of life during and after cancer treatment. Analysis of his recent publication record reveals a strong focus on cardiorespiratory fitness outcomes in cancer survivors, with particular attention to breast cancer populations. His research employs diverse methodologies including randomized controlled trials, systematic reviews, and novel approaches to exercise dose reporting. A significant portion of his work examines the intersection of exercise physiology and cardiovascular health in cancer contexts, reflecting the growing field of cardio-oncology. As an educator, Dr. Nilsen serves as course leader for 'Exercise and Cancer' (THP303), a course developed in collaboration with Oslo University Hospital that provides certification as an AKTIV instructor through the Aktiv mot kreft foundation. He lectures extensively on exercise interventions for cancer patients and leads research studies investigating the effects of exercise on various side effects and late effects of cancer treatment. Dr. Nilsen is actively involved with the Norwegian Exercise Oncology Network (NEON) and collaborates extensively with Oslo University Hospital. His research program includes multiple clinical trials examining exercise interventions across different cancer types and treatment phases, with a particular emphasis on translating research findings into practical clinical applications for cancer rehabilitation.

• Lung Cancer Screening
• Lung Cancer
• Respiratory Medicine
• +۵ مورد دیگر

Annette McWilliams is a Clinical Associate Professor at the UWA Medical School, specifically affiliated with the Centre for Respiratory Health at The University of Western Australia. Her work primarily focuses on lung cancer screening programs, respiratory medicine, and medical imaging applications in oncology. Her research expertise spans several key areas in respiratory health and cancer screening: Lung Cancer Screening methodologies and implementation Low-dose computed tomography applications Management of lung nodules and incidental findings Quality indicators for lung cancer screening programs Population-based approaches to lung cancer prevention Coronary artery calcification assessment in high-risk populations Recent research trends show Dr. McWilliams has been deeply involved in developing and evaluating lung cancer screening programs, particularly focusing on practical implementation challenges, quality metrics, and management protocols for screen-detected abnormalities. Her work often involves large-scale observational studies and international collaborations across Australia and Canada to establish evidence-based guidelines for lung cancer screening. Dr. McWilliams has secured significant research funding from multiple sources including the Department of Health (Western Australia) and the NHMRC National Health and Medical Research Council. Her current projects focus on assessing CT infrastructure readiness for lung cancer screening and evaluating lung cancer screening eligibility criteria across diverse populations. Her scholarly impact is substantial with an h-index of 11 and over 1000 citations, reflecting significant contributions to respiratory medicine and oncology. Her work contributes to UN Sustainable Development Goals related to health and wellbeing, particularly in improving early cancer detection and treatment.

Jarett D. Berryمشاهده پروفایل

استاد

• Cardiovascular Epidemiology
• Cardiovascular Disease Prevention
• Hypertension Management
• +۳ مورد دیگر

Jarett D. Berry, MD, serves as the Roosth Distinguished Professor in Clinical Research and Professor and Chairman of the Department of Internal Medicine at The University of Texas at Tyler School of Medicine, with additional appointments in Cardiology. A leading cardiovascular epidemiologist, he directs an NIH-funded research program focused on lifespan cardiovascular disease prevention and serves as Associate Editor for Circulation . Previously Principal Investigator of the Dallas Heart Study, his work bridges clinical practice and population health research. Educational background includes: BS in Biology, Baylor University MD, UT Southwestern Internal Medicine Residency, UT Southwestern Cardiology Fellowship, Northwestern University Research Fellowship in Cardiovascular Epidemiology, Northwestern University MS in Clinical Investigation, Northwestern University Dr. Berry's research centers on cardiovascular epidemiology with emphasis on blood pressure management , cardiac biomarkers , and lifestyle interventions for disease prevention. His work investigates how physical activity, fitness, and obesity impact heart failure and coronary artery disease across diverse populations, particularly leveraging large cohort studies like SPRINT and Jackson Heart Study to address health disparities. He pioneers precision medicine approaches using biomarkers for risk stratification in hypertension and valvular disease. Analysis of his 15 most recent publications (2024-2025) reveals dominant themes in precision cardiovascular medicine and secondary trial analyses . Key trends include biomarker-guided blood pressure management (SPRINT trial), fitness-COVID interactions (Cooper Center Study), and developmental origins of cardiac disease in preterm populations. His work consistently bridges epidemiology with clinical translation, focusing on individualized treatment benefits and health equity. Scientific recognition includes: Roosth Distinguished Professor in Clinical Research As Principal Investigator of multiple NIH-funded projects including the Dallas Heart Study, Dr. Berry secures substantial grant support for cardiovascular epidemiology research. His program analyzes longitudinal cohorts to develop personalized prevention strategies, with recent grants focusing on blood pressure control, biomarker validation, and exercise interventions. While specific advisees aren't listed, his leadership role involves mentoring medical students, residents, and junior faculty in cardiovascular research methodology. Current projects integrate SPRINT, Cooper Center, and Jackson Heart Study data to address cardiovascular disparities in aging populations. Dr. Berry directs a collaborative research team utilizing multi-cohort data from SPRINT, Dallas Heart Study, Cooper Center, and Jackson Heart Study. His group employs advanced epidemiological methods to analyze cardiac biomarkers, imaging data, and lifestyle factors across diverse populations, with particular focus on translating findings into clinical prevention strategies for high-risk communities.